Undergraduate Medical Education
Doctor of Medicine (M.D.)
The Long-CO (Long School of Medicine COVID-19 Medical Student Response Team) Evidence-based Medicine Team is composed of medical students and faculty advisors. The medical students formed four sub teams: Epidemiology, Diagnostics, Clinical Presentation, and Treatment to review current literature and create executive summaries and information sheets summarizing the literature for use by clinicians throughout the COVID-19 pandemic.
Please fill out our evaluation survey to provide your feedback in order to help improve the effectiveness on the summaries.
Student co-leaders: Cynthia Jiang and Noah Hodson
Epidemiology
- General population
- Marginalized population
- Medically at-risk population
- Masks
- Transmission
Medical Students: Current Team Leader - Phat Do (MS1); Team members - Chase Ballard (MS3), Alexis Lorio (MS1), Omar Akram (MS4), Dhyan Dave (MS1).
Faculty Advisor: Jason Rosenfeld, DrPH, MPH, Assistant Director of Global Health, Center for Medical Humanities & Ethics and Assistant Professor of Medicine-Research.
Resources Developed:
- SARS-CoV 2 Epidemiology Executive Summary - November 15, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary - November 15, 2021
- SARS-CoV 2 Vaccinations Executive Summary - November 15, 2021
- Information sheets with references:
- African American Population
- City Strategies and Plans
- Elderly Population
- Extending Usability of N95s
- Incarcerated
- Indirect Effects
- LatinX Population
- LGBTQ+ Population
- Male Population
- Mask Wearing by the Public
- New Strains
- Pediatric Population
- Stay at Home Orders Effectiveness
- Transmission in Droplet vs Aerosolized Form
- Transmission from Objects
- Vaccination
- Vertical Transmission
Diagnostics
- Who to test
- PCR
- Serology
- Status of Texas & US Testing
- Key populations
Medical Students: Current Team Leader - Sarah El-Agha (MS2); Team members - Anna Tomotaki (MS2), Rebecca Wang (MS2), Hannah Cook (MS2), Bahar Momin (MS1), Meghana Koleti (MS4), Kristin Park (MS2).
Faculty Advisor: Barbara Taylor, MD, MS, Assistant Dean of MD/MPH Program, Associate Professor of Infectious Diseases, Department of Medicine.
Resources Developed:
Clinical Presentation
- Typical presentation
- Key groups for atypical presentation
- Risk factors for severe disease, morbidity and mortality
- Common complications
Medical Students: Current Team Leader - Ashley Andrew (MS2); Team members - Noah Hodson (MS4), Cynthia Jiang (MS4), Salma Yazji (MS3), Vishal Rajesh (MS2), Basmah Barkatullah (MS2), Aditi Sharma (MS4), Sijil Patel (MS4).
Faculty Advisor: Philip Ponce, MD, Assistant Professor of Infectious Disease, Department of Medicine.
Resources Developed:
Treatment
- Supportive care
- Direct-acting agents
Medical Students: Current Team Leaders - Keerthi Thallapureddy (MS4) and Derrick Draeger (MS2); Team members - Roma Ahuja (MS2), Theodora Winter (MS2), Aditi Sharma (MS4), Jeffrey Xia (MS4), Sabi Shresta (MS4), Christopher Worrell (MS2), and Dalton Jones (MS1).
Faculty Advisors: Kristi Traugott, PharmD, BCPS, BCIDP, Clinical Pharmacy Specialist, Infectious Disease and Elizabeth Hand, PharmD, BCIDP, Clinical Pharmacy Specialist, Infectious Disease.
Resources Developed:
Archived Executive Summaries
Epidemiology:
- SARS-CoV 2 Epidemiology - Populations Executive Summary - May 18, 2020
- SARS-CoV 2 Epidemiology - Impact on Health Systems Executive Summary - May 18, 2020
- SARS-CoV 2 Epidemiology - Populations Executive Summary - June 1, 2020
- SARS-CoV 2 Epidemiology - Impact on Health Systems Executive Summary - June 1, 2020
- SARS-CoV 2 Epidemiology - Populations Executive Summary - June 29, 2020
- SARS-CoV 2 Epidemiology - Impact on Health Systems Executive Summary - June 29, 2020
- SARS-CoV 2 Epidemiology - Populations Executive Summary – July 27, 2020
- SARS-CoV 2 Epidemiology - Impact on Health Systems Executive Summary - July 27, 2020
- SARS-CoV 2 Epidemiology Executive Summary – August 24, 2020
- SARS-CoV 2 Impact on Health Systems Executive Summary – August 24, 2020
- SARS-CoV 2 Epidemiology Executive Summary – September 21, 2020
- SARS-CoV 2 Impact on Health Systems Executive Summary – September 21, 2020
- SARS-CoV 2 Epidemiology Executive Summary - October 12, 2020
- SARS-CoV 2 Impact on Health Systems Executive Summary - October 12, 2020
- SARS-CoV 2 Epidemiology Executive Summary – November 4, 2020
- SARS-CoV 2 Impact on Health Systems Executive Summary – November 4, 2020
- SARS-CoV 2 Epidemiology Executive Summary – November 30, 2020
- SARS-CoV 2 Impact on Health Systems Executive Summary – November 30, 2020
- SARS-CoV 2 Epidemiology Executive Summary – January 4, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary – January 4, 2021
- SARS-CoV 2 Epidemiology Executive Summary – February 1, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary – February 1, 2021
- SARS-CoV 2 Epidemiology Executive Summary – February 22, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary – February 22, 2021
- SARS-CoV 2 Epidemiology Executive Summary – March 17, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary – March 17, 2021
- SARS-CoV 2 Epidemiology Executive Summary – April 5, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary – April 5, 2021
- SARS-CoV 2 Epidemiology Executive Summary – April 26, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary – April 26, 2021
- SARS-CoV 2 Epidemiology Executive Summary – May 17, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary – May 17, 2021
- SARS-CoV 2 Epidemiology Executive Summary – June 14, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary – June 14, 2021
- SARS-CoV 2 Epidemiology Executive Summary – July 5, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary – July 5, 2021
- SARS-CoV 2 Epidemiology Executive Summary - July 26, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary - July 26, 2021
- SARS-CoV 2 Epidemiology Executive Summary - August 23, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary - August 23, 2021
- SARS-CoV 2 Vaccinations Executive Summary - August 23, 2021
- SARS-CoV 2 Epidemiology Executive Summary - September 21, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary - September 21, 2021
- SARS-CoV 2 Vaccinations Executive Summary - September 21, 2021
- SARS-CoV 2 Epidemiology Executive Summary - October 11, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary - October 11, 2021
- SARS-CoV 2 Vaccinations Executive Summary - October 11, 2021
- SARS-CoV 2 Epidemiology Executive Summary - October 25, 2021
- SARS-CoV 2 Impact on Health Systems Executive Summary - October 25, 2021
- SARS-CoV 2 Vaccinations Executive Summary - October 25, 2021
Diagnostics:
- SARS-CoV 2 Diagnostics Executive Summary – May 18, 2020
- SARS-CoV 2 Diagnostics Executive Summary – June 1, 2020
- SARS-CoV 2 Diagnostics Executive Summary – June 29, 2020
- SARS-CoV 2 Diagnostics Executive Summary – July 27, 2020
- SARS-CoV 2 Diagnostics Executive Summary – August 24, 2020
- SARS-CoV 2 Diagnostics Executive Summary – September 21, 2020
- SARS-CoV 2 Diagnostics Executive Summary - October 12, 2020
- SARS-CoV 2 Diagnostics Executive Summary – November 4, 2020
- SARS-CoV 2 Diagnostics Executive Summary – November 30, 2020
- SARS-CoV 2 Diagnostics Executive Summary – January 4, 2021
- SARS-CoV 2 Diagnostics Executive Summary – February 1, 2021
- SARS-CoV 2 Diagnostics Executive Summary – February 22, 2021
- SARS-CoV 2 Diagnostics Executive Summary – March 17, 2021
- SARS-CoV 2 Diagnostics Executive Summary – April 5, 2021
- SARS-CoV 2 Diagnostics Executive Summary – April 26, 2021
- SARS-CoV 2 Diagnostics Executive Summary – May 17, 2021
- SARS-CoV 2 Diagnostics Executive Summary – June 14, 2021
- SARS-CoV 2 Diagnostics Executive Summary – July 5, 2021
- SARS-CoV 2 Diagnostics Executive Summary – July 26, 2021
- SARS-CoV 2 Diagnostics Executive Summary – August 23, 2021
- SARS-CoV 2 Diagnostics Executive Summary – September 21, 2021
- SARS-CoV 2 Diagnostics Executive Summary – October 11, 2021
- SARS-CoV 2 Diagnostics Executive Summary – October 25, 2021
Clinical Presentation:
- SARS-CoV 2 Clinical Presentation Executive Summary - May 18, 2020
- SARS-CoV 2 Clinical Presentation Executive Summary - June 1, 2020
- SARS-CoV 2 Clinical Presentation Executive Summary - June 29, 2020
- SARS-CoV 2 Clinical Presentation Executive Summary - July 27, 2020
- SARS-CoV 2 Clinical Presentation Executive Summary - August 24, 2020
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - August 24, 2020
- SARS-CoV 2 Clinical Presentation Executive Summary - September 21, 2020
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - September 21, 2020
- SARS-CoV 2 Clinical Presentation Executive Summary - October 12, 2020
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - October 12, 2020
- SARS-CoV 2 Clinical Presentation Executive Summary - November 4, 2020
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - November 4, 2020
- SARS-CoV 2 Clinical Presentation Executive Summary - November 30, 2020
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - November 30, 2020
- SARS-CoV 2 Clinical Presentation Executive Summary - January 4, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - January 4, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - February 1, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - February 1, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - February 22, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - February 22, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - March 17, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - March 17, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - April 5, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - April 5, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - April 26, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - April 26, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - May 17, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - May 17, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - June 14, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - June 14, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - July 5, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - July 5, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - July 26, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - July 26, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - August 23, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - August 23, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - September 21, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - September 21, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - October 11, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - October 11, 2021
- SARS-CoV 2 Clinical Presentation Executive Summary - October 25, 2021
- SARS-CoV 2 Clinical Presentation - Pediatric Executive Summary - October 25, 2021
Treatment:
- SARS-CoV 2 Treatment Executive Summary - May 18, 2020
- SARS-CoV 2 Treatment Executive Summary - June 1, 2020
- SARS-CoV 2 Treatment Executive Summary - June 29, 2020
- SARS-CoV 2 Treatment Executive Summary - July 27, 2020
- SARS-CoV 2 Treatment Executive Summary - August 24, 2020
- SARS-CoV 2 Treatment Executive Summary - September 21, 2020
- SARS-CoV 2 Treatment Executive Summary - October 12, 2020
- SARS-CoV 2 Treatment Executive Summary - November 4, 2020
- SARS-CoV 2 Treatment Executive Summary - November 30, 2020
- SARS-CoV 2 Treatment Executive Summary - January 4, 2021
- SARS-CoV 2 Treatment Executive Summary - February 1, 2021
- SARS-CoV 2 Treatment Executive Summary - February 22, 2021
- SARS-CoV 2 Treatment Executive Summary - March 17, 2021
- SARS-CoV 2 Treatment Executive Summary - April 5, 2021
- SARS-CoV 2 Treatment Executive Summary - April 26, 2021
- SARS-CoV 2 Treatment Executive Summary - May 17, 2021
- SARS-CoV 2 Treatment Executive Summary - June 14, 2021
- SARS-CoV 2 Treatment Executive Summary - July 5, 2021
- SARS-CoV 2 Treatment Executive Summary - July 26, 2021
- SARS-CoV 2 Treatment Executive Summary - August 23, 2021
- SARS-CoV 2 Treatment Executive Summary - September 21, 2021
- SARS-CoV 2 Treatment Executive Summary - October 11, 2021
- SARS-CoV 2 Treatment Executive Summary - October 25, 2021